Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2qzs | ADP | Glycogen synthase | 2.4.1.21 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2qzs | ADP | Glycogen synthase | 2.4.1.21 | 1.000 | |
| 3cx4 | ADP | Glycogen synthase | 2.4.1.21 | 0.622 | |
| 2r4t | ADP | Glycogen synthase | 2.4.1.21 | 0.566 | |
| 2r4u | ADP | Glycogen synthase | 2.4.1.21 | 0.557 | |
| 3dy8 | 5GP | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.462 | |
| 2yy2 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.447 | |
| 3dys | 5GP | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.446 | |
| 3nmp | PYV | Abscisic acid receptor PYL2 | / | 0.442 | |
| 3sig | AR6 | Uncharacterized protein | / | 0.442 |